BRCA2 and breast carcinoma: Until recently, the process of SV discovery in disease genes like BRCA1 and BRCA2 required gene-specific probes to amplify and quantify the genomic DNA structure and amount, which made it difficult to identify new genes contributing to breast cancer risk though mechanisms such as SV.